This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Early Registration Savings Deadline Expires In

  • 00
    DAYS
  • 00
    HRS
  • 00
    MINS
  • 00
    SECS
Delivered as a Hybrid Event from September 20-30, 2021
Live In-Person Experience Delivered September 20-23Boston Convention and Exhibition Center
Menu
Book
keyboard_arrow_right

CONFERENCE DAY TWO - EST/EDT (Eastern Daylight, GMT-4)

keyboard_arrow_leftSearch & Filter
search

CONFERENCE DAY TWO - EST/EDT (Eastern Daylight, GMT-4)

search
7:30am - 7:50am20 mins
Coffee & Registration
    7:50am - 8:00am10 mins
    Chairperson’s Opening remarks
    • Miguel Forte - CEO, Bone Therapeutics, Belgium
    Allogeneic CAR & T Cell Therapies – iPSc, NK, Gene Editing & Universal Cells
    8:00am - 8:30am30 mins
    Joint Plenary Session
    PANEL: Next Generation CAR Strategies – Allo, NK and Macrophages for Treating Multiple Patients
    • Bruno Marques - Head of Process & Product Development, Century Therapeutics
    • Michael Klichinsky - Co-Founder and VP, Discovery Research, Carisma Therapeutics
    • Kathryn Corzo - Head of Development Oncology Cell Therapies, Takeda
    8:30am - 9:00am30 mins
    Joint Plenary Session
    Azzur Cleanrooms on Demand – Addressing the Buy vs Build Conundrum for Cell and Gene Therapy Manufacturing
    • Ravi Samavedam - President & COO of Azzur Cleanrooms on Demand™, Azzur Group, USA
    9:00am - 9:30am30 mins
    Joint Plenary Session
    Charting a new path. Reimagining Automation in Cell Therapy Manufacturing.
    • Fabian Gerlinghaus - Co-Founder & CEO, Cellares
    9:30am - 10:30am60 mins
    Morning Coffee and Networking
      10:30am - 10:50am20 mins
      Cell Therapy/ Gene Edited Ex Vivo Cell Therapy
      Building an Analytical Toolbox for Potency Testing for Next Generation CARs
      • Daniel Hui - Associate Director – Product Characterization/Clinical Assay Development, Tmunity Therapeutics
      10:30am - 11:00am30 mins
      In Vivo Gene Therapy
      Measuring the DNA cargo of Adeno-Associated Viruses using nanofluidic resonators
      • Georgios Katsikis - Postdoctoral Associate, Massachusetts Institute of Technology, USA
      10:50am - 11:10am20 mins
      Cell Therapy/ Gene Edited Ex Vivo Cell Therapy
      An Introduction to Cell and Gene Therapy Validation Challenges
      • Yogesh Waghmare - Director, CMC Lead, bluebird bio
      11:00am - 11:30am30 mins
      In Vivo Gene Therapy
      Developing a Fed-Batch process to increase productivity of the Bac/Sf9 Platform
      • Krishanu Mathur - CMC, Early & Late Stage Gene Therapy, Voyager Therapeutics, USA
      11:10am - 11:30am20 mins
      Cell Therapy/ Gene Edited Ex Vivo Cell Therapy
      Potency Assay Development for Commercialization
      • Knut Niss - Chief Technology Officer, Mustang Bio
      11:30am - 12:00pm30 mins
      Cell Therapy/ Gene Edited Ex Vivo Cell Therapy
      Spotlight Presentation - Halo Labs
      • Bernardo Cordovez - Chief Science Officer and Founder, Halo Labs, USA
      11:30am - 12:00pm30 mins
      In Vivo Gene Therapy
      Platform Manufacturing Approach for Adeno Associated Virus: Accelerated Time and Cost Saving
      • Elie Hanania - Director of Upstream Process Development, FUJIFILM Diosynth Biotechnologies
      12:00pm - 1:25pm85 mins
      Lunch & Networking
        1:25pm - 1:30pm5 mins
        Cell Therapy
        Chairperson's Opening Remarks
          1:25pm - 1:30pm5 mins
          Gene Edited Ex Vivo Cell Therapy
          Chairperson's Opening Remarks
            1:25pm - 1:30pm5 mins
            In Vivo Gene Therapy
            Chairperson's Opening Remarks
            • David Dobnik - Senior Research Associate, National Institute of Biology, Slovenia
            1:30pm - 2:00pm30 mins
            Cell Therapy
            Identifying and Managing Sources of Variability in Cell Therapy Manufacturing and Clinical Trials
            • Lara Ionescu Silverman - Senior Director, Research and Development, DiscGenics
            1:30pm - 2:00pm30 mins
            Gene Edited Ex Vivo Cell Therapy
            Is Gene Editing a Gene Therapy or Cell Therapy or both? Where does it fit?
            • Devyn Smith - Chief Executive Officer, Arbor Biotechnologies, Inc.
            1:30pm - 2:00pm30 mins
            In Vivo Gene Therapy
            Challenges for Potency Assay Development for Gene Therapies & the Matrix Approach
            • Roland Pach - Project Leader, F.Hoffmann-La Roche, Switzerland
            • Christina Grigoriadou - Senior Scientist, AstraZeneca
            2:00pm - 2:30pm30 mins
            Cell Therapy
            Investigating Analytical Challenges for Cell & Gene Therapies
            • Richard Rogers, Ph.D. - Principal Scientist, Bristol Myers Squibb, USA
            2:00pm - 2:30pm30 mins
            Gene Edited Ex Vivo Cell Therapy
            Novel Modalities to Address CAR-T Challenges - NK Cell Case Study
            • Bruno Marques - Head of Process & Product Development, Century Therapeutics
            2:00pm - 2:30pm30 mins
            In Vivo Gene Therapy
            Developing Functional Potency Assay for Gene Therapy Products
            • Arkadi Manukyan - Scientist, Analytical Development, Sanofi, USA
            2:30pm - 2:45pm15 mins
            Cell Therapy
            Spotlight Presentation - Emulate
              2:30pm - 3:00pm30 mins
              Gene Edited Ex Vivo Cell Therapy
              Spotlight Presentation
                2:30pm - 3:00pm30 mins
                In Vivo Gene Therapy
                Spotlight Presentation - Cytiva
                  2:45pm - 3:00pm15 mins
                  Cell Therapy
                  Spotlight Presentation
                    3:00pm - 4:00pm60 mins
                    Refreshment Break in the Poster & Exhibit Hall
                      4:00pm - 4:30pm30 mins
                      Cell Therapy
                      Manufacturing Tissues at Scale - A Platform that Enables Precise Control Over iPS Cell Fate in their Natural Environment
                      • Marinna Madrid - Co-Founder, Cellino
                      4:00pm - 4:30pm30 mins
                      Gene Edited Ex Vivo Cell Therapy
                      Commercialization & Process Development Approaches for Allo CART
                      • Sarah Snykers - QC Manager, Celyad
                      4:00pm - 4:30pm30 mins
                      In Vivo Gene Therapy
                      Rational Design & Development of Vector Genome Assay by ddPCR
                      • Santoshkumar Khatwani - Associate Director, Analytical Development, Sangamo Therapeutics
                      4:30pm - 5:00pm30 mins
                      Cell Therapy
                      Autologous iPS Cell Therapy for Macular Degeneration: From Bench-to-Bedside
                      • Kapil Bharti - Earl Stadtman Tenure-Track Investigator, National Eye Institute, National Institutes of Health
                      4:30pm - 5:00pm30 mins
                      Gene Edited Ex Vivo Cell Therapy
                      Unlocking the Bottlenecks in The Supply Chain of Autologous Therapies: A Patient-Centric Approach
                      • Gabrielle Humphrey - CMC Consultant, VECTAPLUS (formerly Adaptimmune)
                      4:30pm - 5:00pm30 mins
                      In Vivo Gene Therapy
                      Emerging tools and needs for AAV vector characterization
                      • Fabien Dorange - Head Analytical CMC, Genethon
                      5:00pm - 5:30pm30 mins
                      Cell Therapy
                      Spotlight Presentation
                        5:00pm - 5:30pm30 mins
                        Gene Edited Ex Vivo Cell Therapy
                        Spotlight Presentation
                          5:00pm - 5:30pm30 mins
                          In Vivo Gene Therapy
                          Spotlight Presentation
                            6:30pm - 8:00pm90 mins
                            BWB Lawn on D Party
                              CONFERENCE DAY ONE
                              NextCONFERENCE DAY THREE
                              Filter
                              Streams
                              Formats
                              Choose Day